Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Revenue

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,669 Cr₹1,541 Cr₹1,242 Cr₹1,107 Cr₹968 Cr

What is the latest Revenue of INDOCO REMEDIES ?

The latest Revenue ratio of INDOCO REMEDIES is ₹1,669 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,669 Cr
Mar2023₹1,541 Cr
Mar2022₹1,242 Cr
Mar2021₹1,107 Cr
Mar2020₹968 Cr

How is Revenue of INDOCO REMEDIES Trending?

Years Revenue % Change
Mar2024 ₹1,669 Cr
8.30
Mar2023 ₹1,541 Cr
24.10
Mar2022 ₹1,242 Cr
12.19
Mar2021 ₹1,107 Cr
14.26
Mar2020 ₹968 Cr -

Compare Revenue of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,883.6 Cr 7.1% 20.8% -1.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,017.0 Cr -0.2% -0.5% 10.7% Stock Analytics
DIVIS LABORATORIES ₹181,867.0 Cr 4% 4.8% 50.5% Stock Analytics
CIPLA ₹122,451.0 Cr 0.4% 3.1% 1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,620.0 Cr 5.9% 9.1% 23% Stock Analytics
DR REDDYS LABORATORIES ₹106,572.0 Cr -4.8% 2.2% 2.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

7.1%

20.8%

-1.9%

SENSEX

2%

2.8%

6.4%


You may also like the below Video Courses